XML 16 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Beginning balance at Dec. 31, 2023 $ 35 $ 559,214 $ (198,686) $ (1,613) $ 358,950
Beginning balance (in shares) at Dec. 31, 2023 354,148,173        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options   18     18
Issuance of common stock upon exercise of stock options (in shares) 197,127        
Restricted stock units vested (in shares) 18,869        
Forfeitures of Earn-Out Restricted Shares (in shares) (711,298)        
Forfeitures of Restricted Stock Awards   (50)     (50)
Forfeitures of Restricted Stock Awards (in shares) (35,253)        
Stock-based compensation   4,784     4,784
Net loss     (15,557)   (15,557)
Foreign currency translation adjustments       (457) (457)
Unrealized loss on short-term investments       (299) (299)
Ending balance at Mar. 31, 2024 $ 35 563,966 (214,243) (2,369) 347,389
Ending balance (in shares) at Mar. 31, 2024 353,617,618        
Beginning balance at Dec. 31, 2024 $ 36 579,378 (298,871) (2,233) 278,310
Beginning balance (in shares) at Dec. 31, 2024 361,557,285        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options   8     8
Issuance of common stock upon exercise of stock options (in shares) 50,000        
Restricted stock units vested (in shares) 3,284,079        
Forfeitures of Earn-Out Restricted Shares (in shares) (2,797)        
Forfeitures of Restricted Stock Awards   (31)     (31)
Forfeitures of Restricted Stock Awards (in shares) (37,735)        
Stock-based compensation   3,973     3,973
Net loss     (12,432)   (12,432)
Foreign currency translation adjustments       47 47
Unrealized loss on short-term investments       (20) (20)
Ending balance at Mar. 31, 2025 $ 36 $ 583,328 $ (311,303) $ (2,206) $ 269,855
Ending balance (in shares) at Mar. 31, 2025 364,850,832